Press Releases CohBar, Inc.

Equities

CWBR

US19249J3077

Market Closed - OTC Markets Other stock markets 15:01:52 09/05/2024 BST			5-day change	1st Jan Change
0.7601 ^USD	-5.11%		-4.99%	+2.72%

01-23	North American Morning Briefing : Stock Futures Steady as Earnings Season Ramps Up	DJ
01-16	North American Morning Briefing : Stock Futures -2-	DJ

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

CohBar, Inc., Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard, Transfer of Listing	11-28	AQ
CohBar, Inc.: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (Form 8-K)	11-27	BU
CohBar : Termination of Material Agreement - Form 8-K	11-01	PU
COHBAR INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of CohBar, Inc. - CWBR	19/09/23	BU
CohBar Reports Second Quarter 2023 Financial Results	14/08/23	AQ
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates WTT, CWBR, DM	17/07/23	PR
Morphogenesis, Inc. and CohBar, Inc. Announce Positive Results from Phase 1b Trial of IFx-Hu2.0, a Novel Personalized Cancer Vaccine, in Checkpoint Inhibitor Resistant Advanced Merkel Cell Carcinoma (MCC) and Cutaneous Squamous Cell Carcinoma (cSCC)	05/06/23	AQ
Morphogenesis, Inc. and CohBar, Inc. Announce Acceptance of Abstract for Poster Presentation at the 2023 American Society of Clinical Oncology Annual Meeting	31/05/23	AQ
COHBAR INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of CohBar, Inc. - CWBR	31/05/23	BU
Morphogenesis, Inc. and CohBar, Inc. Announce Acceptance of Abstract for Poster Presentation at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting	30/05/23	AQ
Shareholder Alert: Ademi LLP investigates whether CohBar, Inc. has obtained a Fair Price in its transaction with Morphogenesis, Inc.	25/05/23	PR
CWBR Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of CohBar, Inc. Is Fair to Shareholders	23/05/23	BU
CohBar, Inc. and Morphogenesis, Inc. Enter into Definitive Merger Agreement to Advance an Innovative Late-stage Clinical Immuno-oncology Pipeline of Therapies to Overcome Resistance to Cancer Immunotherapy	23/05/23	AQ
COHBAR, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	09/03/23	AQ
CohBar : Current Report - Form 8-K	07/12/22	PU
COHBAR, INC. : Other Events (form 8-K)	07/12/22	AQ
COHBAR, INC. : Other Events (form 8-K)	17/11/22	AQ
CohBar Reports Third Quarter 2022 Financial Results and Highlights Recent Corporate Progress	09/11/22	AQ
Note 2 - Liquidity and Management's Plans	08/11/22	AQ
CohBar Reports Third Quarter 2022 Financial Results and Highlights Recent Corporate Progress	08/11/22	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases CohBar, Inc.

Equities

CWBR

US19249J3077

Press Releases

Filters